Evidence map›Paper›PMID 39518700›Full record

ArticleJournal of clinical medicine2024

Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study.

Luana Fianchi, Matteo Bonanni, Alessandra Borchiellini, Federica Valeri, Gaetano Giuffrida, Stephanie Grasso, Claudio Fozza, Michele Ponta, Giovanni L Tiscia, Elvira Grandone and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Luana FianchiHematology Unit, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, 00168 Rome, Italy.
Matteo BonanniHematology Unit, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, 00168 Rome, Italy.
Alessandra BorchielliniRegional Reference Center for Thrombotic and Haemorrhagic Disorders of Hematology, Division Department of Hematology and Oncology, A.O.U. Città della Salute e della Scienza di Torino, 10126 Torino, Italy.ORCID 0000-0002-8618-145X
Federica ValeriRegional Reference Center for Thrombotic and Haemorrhagic Disorders of Hematology, Division Department of Hematology and Oncology, A.O.U. Città della Salute e della Scienza di Torino, 10126 Torino, Italy.
Gaetano GiuffridaUOS e Centro di Riferimento Regionale di Malattie Ematologiche Rare, Division of Haematology, A.O.U Policlinico-S. Marco, 95123 Catania, Italy.ORCID 0000-0003-4947-3338
Stephanie GrassoUOS e Centro di Riferimento Regionale di Malattie Ematologiche Rare, Division of Haematology, A.O.U Policlinico-S. Marco, 95123 Catania, Italy.
Claudio FozzaDepartment of Clinical and Experimental Medicine, University of Sassari, 07100 Sassari, Italy.
Michele PontaDepartment of Clinical and Experimental Medicine, University of Sassari, 07100 Sassari, Italy.
Giovanni L TisciaThrombosis and Hemostasis Unit, Fondazione IRCCS "Casa Sollievo della Sofferenza", S. Giovanni Rotondo, and Unità di Ostetricia e Ginecologia, Università degli Studi di Foggia, 71121 Foggia, Italy.
Elvira GrandoneThrombosis and Hemostasis Unit, Fondazione IRCCS "Casa Sollievo della Sofferenza", S. Giovanni Rotondo, and Unità di Ostetricia e Ginecologia, Università degli Studi di Foggia, 71121 Foggia, Italy.
Nicola VianelliIRCCS Azienda Ospedaliero, Istituto di Ematologia "Seràgnoli", Universitaria di Bologna, 40121 Bologna, Italy.
Alessandra DedolaIRCCS Azienda Ospedaliero, Istituto di Ematologia "Seràgnoli", Universitaria di Bologna, 40121 Bologna, Italy.
Teresa PirozziService of Haemorrhagic and Thrombotic Diseases, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, 00168 Rome, Italy.
Monica SaccoDipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica S. Cuore, 00168 Rome, Italy.ORCID 0000-0002-2395-2691
Stefano LancellottiService of Haemorrhagic and Thrombotic Diseases, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, 00168 Rome, Italy.ORCID 0000-0002-8090-9040
Raimondo De CristofaroService of Haemorrhagic and Thrombotic Diseases, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, 00168 Rome, Italy.ORCID 0000-0002-8066-8849

Funding

Sanofi Italia ROSSCAPLI/2021
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADAMTS13caplacizumabthrombotic thrombocytopenic purpuravon Willebrand factor

Identifiers

PMID39518700
PMCPMC11546578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.